U.S. and European Clinical Development for Asian MedTech Startups
This webinar focuses on key considerations for Asian MedTech companies interested in engaging in clinical trials in these geographies. The webinar examines the clinical trial landscape in each region, including patient pathways, interactions with clinical trial sites, and key metrics related to startup timelines, trial execution timelines, and other key dates. We discuss key items for consideration, including clinical trial budgets, accurate timelines, and risk mitigation strategies, including the lingering effects of COVID-19 on the clinical trial area in these geographies.
Who should watch this webinar?
MedTech, digital health and IVD startups, and Small & Medium-sized Enterprises based in the Asia Pacific planning to expand commercially to Europe and North America.
This webinar answers the following questions:
- What is the site startup/ethics committee process for clinical trials in these geographies?
- How to estimate trial timelines and costs for clinical trials in these geographies?
- How can sponsors interact with site Principal Investigators and study teams, including the role of CROs?
- What are risk mitigation strategies and factors for clinical trials in these geographies?
This webinar is part of the free webinar series “Expanding Beyond APAC” launched to discuss the strategies, challenges, and best practices of entering new markets and scaling beyond the Asia Pacific for MedTech companies.
The webinar series is prepared together with APACMed, Asia Pacific’s regional trade association which represents manufacturers and providers of medical equipment and devices, in-vitro diagnostics, digital health; as well as local associations and other key stakeholders within the medical technology industry.
Meet the Speakers
Christopher has 15 years of experience in clinical research, with a focus on clinical trial design and operations. As a strategist, Christopher works identifies client’s key needs early and creates tailored, targeted plans for clinical development and market success. Throughout his career, Christopher has worked closely with small-to-medium biotech and pharmaceutical oncology companies, developing novel technologies.
Kenny leads business development efforts and initiatives for early-stage healthcare companies in Alira Health. His background covers a wide array of indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.